Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase

Immunological Investigations

Volumn 38, Issue 7, 2009, Pages 602-612

  Wang, Dunjing ^a   Lu, Zhengqi ^a   Hu, Liping ^b   Zhang, Yuefeng ^a   Hu, Xueqiang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Experimental autoimmune encephalomyelitis; Inducible nitric oxide synthase; Macrolide antibiotics; Nitric oxide

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; FREUND ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; IMMUNIZATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BLOTTING, WESTERN; CELLS, CULTURED; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CLARITHROMYCIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LEUKOCYTES, MONONUCLEAR; MACROLIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLIGOPEPTIDES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 70350668790     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130903062194     Document Type: Article

References (27)

1. Asano, K., Kamakazu, K., Hisamitsu, T., Suzaki, H. (2003). Suppressive activity of macrolide antibiotics on nitric oxide production from nasal polyp fibroblasts in vitro. Acta Otolaryngol. 123:1064-1069. (Pubitemid 38021523)
2. Bouwman, J. J., Visseren, F. L., Bevers, L. M., van der Vlist, W. E., Bouter, K. P., Diepersloot, R. J. (2005). Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells. Eur. J. Clin. Invest. 35:573-582.
3. Cao, X. Y., Dong, M., Shen, J. Z., Wu, B. B., Wu, C. M., Du, X. D., Wang, Z., Qi, Y. T., Li, B. Y. (2006). Tilmicosin and tylosin have anti-inflammatory properties via modulation of COX-2 and iNOS gene expression and production of cytokines in LPS-induced macrophages and monocytes. Int. J. Antimicrob. Agents 27:431-438.
4. Colasanti. M., Suzuki. H. (2000). The dual peronality of NO. Trends Pharmacol. Sci. 21:249-252.
5. Contini, C., Cultrera, R., Seraceni, S., Castellazzi, M., Granieri, E., Fainardi, E. (2004). Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult. Scler. 10:360-369.
6. Cowden, W. B., Cullen, F. A., Staykova, M. A., Willenborg, D. O. (1998). Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1-8.
7. Dalton, D. K., Wittmer, S. (2005). Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: Evidence from EAE in iNOS KO mice. J. Neuroimmunol. 160:110-121.
8. Fainardi, E., Castellazzi, M., Seraceni, S., Granieri, E., Contini, C. (2008). Under the microscope: Focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr. Neurovasc. Res. 5:60-70.
9. Fenyk-Melody, J. E., Garrison, A. E., Brunnert, S. R., Weidner, J. R., Shen, F., Shelton, B. A., Mudgett, J. S. (1998). Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol.160:2940-2946.
10. Gao, X., Ray, R., Xiao, Y., Ray, P. (2008). Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustardexposed airway epithelial cells. Basic Clin. Pharmacol. Toxicol.103:255-261.
11. Ianaro, A., Ialenti, A., Maffia, P., Sautebin, L., Rombolà, L., Carnuccio, R., Iuvone, T., D'Acquisto, F., Di Rosa, M. (2000). Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 292:156-163.
12. Kahl, K. G., Schmidt, H. H., Jung, S., Sherman, P., Toyka, K. V., Zielasek, J. (2004). Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: Increased T-helper 1 response. Neurosci. Lett. 358:58-62.
13. Kahl K. G., Zielasek, J., Uttenthal, L. O., Rodrigo, J., Toyka, K. V., Schmidt, H. H. (2003). Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J. Neurosci. Res. 73:198-205.
14. Khan, A. A., Slifer, T. R., Araujo, F. G., Remington, J. S. (1999). Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents. 11:121-132.
15. Lotter, K., Höcherl, K., Bucher, M., Kees, F. (2006). In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in mice. J. Antimicrob. Chemother. 58:615-621.
16. Mitsuyama, T., Hidaka, K., Furuno, T., Hara, N. (1998). Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: Enhancement by a 14-membered ring macrolide. Mol. Cell Biochem. 181:157-161.
17. Persichini. T., Cantoni, O., Suzuki, H., Colasanti, M. (2006). Cross-talk between constitutive and inducible NO synthase: An update. Antioxid. Redox. Signal. 8:949-954.
18. Sahrbacher, U. C., Lechner, F., Eugster, H. P., Frei, K., Lassmann, H., Fontana, A. (1998). Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1332-1338.
19. Smith, K. J., Lassmann, H. (2002). The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1:232-241.
20. Sriram, S., Yao, S. Y., Stratton, C., Moses, H., Narayana, P. A., Wolinsky, J. S. (2005). A pilot study to examine the effect of antibiotic therapy on MRI outcomes in relapsing remitting MS. J. Neurol. Sci. 234:87-91.
21. Staykova, M. A., Fordham, S. A., Bartell, G. J., Cowden, W. B., Willenborg, D. O. (2006). Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis. J. Neuroimmunol.176:1- 8.
22. Staykova, M. A., Paridaen, J. T., Cowden, W. B., Willenborg, D. O. (2005). Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 166:147-157.
23. Stratton, C. W., Wheldon, D. B. (2006). Multiple sclerosis: An infectious syndrome involving Chlamydophila pneumoniae. Trends Microbiol. 14:474-479.
24. Tamaoki, J., Kondo, M., Kohri, K., Aoshiba, K., Tagaya, E., Nagai, A. (1999). Macrolide antibiotics protect against immune complex-induced lung injury in rats: Role of nitric oxide from alveolar macrophages. J. Immunol. 163:2909-2915.
25. Teixeira, S. A., Castro, G. M., Papes, F., Martins, M. L., Rogério, F., Langone, F., Santos, L. M., Arruda, P., de Nucci. G., Muscará, M. N. (2002). Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis. Brain Res. Mol. Brain. Res. 99:17-25.
26. Terao, H., Asano, K., Kanai, K., Kyo, Y., Watanabe, S., Hisamitsu, T., Suzaki, H. (2003). Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm. 12:195-202. (Pubitemid 37297187)
27. Woessner, R., Grauer, M. T., Frese, A., Bethke, F., Ginger, T., Hans, A., Treib, J. (2006). Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection 34:342-344.